Crossmark

Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis

Crossref DOI link: https://doi.org/10.1007/s11010-019-03542-7

Published Online: 2019-04-22

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Jun-Won

Oh, Ji Eun

Rhee, Ki-Jong

Yoo, Byung-Su

Eom, Young Woo https://orcid.org/0000-0002-5985-6490
Park, Sang Wook

Lee, Ji Hyun

Son, Jung-Woo

Youn, Young Jin

Ahn, Min-Soo

Ahn, Sung-Gyun

Kim, Jang-Young

Lee, Seung-Hwan

Yoon, Junghan
Funding

Funding for this research was provided by:

Basic Science Research Program through the National Research Foundation of Korea (NRF- 2017R1D1A1A02019212)

Bio & Medical Technology Development Program of the NRF funded by the Korean government, the Ministry of Science, ICT & Future Planning (NRF-2016M3A9B4919711)

Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea.
License Information

Text and Data Mining valid from 2019-04-22
More Information

Article History

Received: 5 July 2018

Accepted: 23 February 2019

First Online: 22 April 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.